AbbVie Inc. (NYSE:ABBV) went higher by +0.16% to close at $ 61.91. The company exchanged total volume of 7.92 million shares throughout course of last trade however it holds an average trading capacity of 8.58 million shares. Shares of company began trading at $61.79 climbed to high of $62.02 touched the low of $61.14.
The company is trading above its 50-day moving averages of 61.25 and up from 200-day moving averages of 58.30. The firm has price to book ratio of 21.53 and its price to sale ratio was 4.20.
AbbVie (ABBV), a global biopharmaceutical company, reported that the U.S. Food and Drug Administration (FDA) has accepted HUMIRA® (adalimumab) for the treatment of non-infectious intermediate, posterior and panuveitis. HUMIRA is now the first and only FDA-accepted non-corticosteroid therapy accessible for adults with non‑infectious intermediate, posterior and panuveitis. This authorization marks the 10th accepted indication for HUMIRA in the United States for immune-mediated diseases.
This month, the European Commission also accepted HUMIRA in the European Union for the treatment of non‑infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.
AbbVie Inc.’s (ABBV) has price-to-cash ratio of 11.64 and price to sale ratio of 4.21. The company net profit margin is 23.00% and gross profit margin is 79.80%. A look on the firm performance, its monthly performance is -1.46% and a quarterly performance of 8.86%. The stock price is moving up from its 20 days moving average with 1.26% and isolated positively from 50 days moving average with 0.87%.
Novartis AG (NYSE:NVS) surged +1.64% and closed the trade at $ 82.51. The company recorded a trading capacity of 1.71 million shares below its three months average daily volume of 2.14 million shares. During the last trade, shares reached to high price of $82.58 and touched the low price of $81.19. The stock’s 50-day moving average is noted at $78.36 and its 200-day moving average is stands at $77.38.
Additionally, the company has a PE ratio of 29.43 and has EPS of 2.80. The company has market capitalization of $196.48B.
The average true range of Novartis AG’s (NVS) is recorded at 1.41 and the relative strength index of the stock stands 63.15. The stock price is going above to its 52 week low with 19.81% and lagging behind from its 52 week high with -19.76%. Analyst recommendation for this stock stands at 2.40. A look on the firm performance, its monthly performance is 3.62% and a quarterly performance of 15.56%. The stock price is trading upbeat from its 200 days moving average with 3.63% and up from 50 days moving average with 6.35%.